Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study

Kelley, Robin Kate ; Sangro, Bruno ; Harris, William ; Ikeda, Masafumi ; Okusaka, Takuji ; Kang, Yoon-Koo ; Qin, Shukui ; Tai, David W-M ; Lim, Ho Yeong ; Yau, Thomas ; Yong, Wei-Peng ; Cheng, Ann-Lii ; Gasbarrini, Antonio ; Damian, Silvia ; Bruix, Jordi ; Borad, Mitesh ; Bendell, Johanna ; Kim, Tae-You ; Standifer, Nathan ; He, Philip ; Makowsky, Mallory ; Negro, Alejandra ; Kudo, Masatoshi ; Abou-Alfa, Ghassan K

Journal of clinical oncology, 2021-09, Vol.39 (27), p.2991-3001 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível